Nalmefene di-ester prodrugs

Details for Australian Patent Application No. 2009239927 (hide)

Owner Janssen Pharmaceutica NV

Inventors Guillaume, Michel Joseph Maurice Andre; Gaekens, Tim

Agent Shelston IP

Pub. Number AU-A-2009239927

PCT Pub. Number WO2009/130270

Priority 08155092.3 24.04.08 EP

Filing date 23 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 489/08 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/130270 Priority application(s): WO2009/130270

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239928-A container liner and a method of discharging a container liner

2009239906-5-methyl-1-(naphthalen-2-yl)-1H-pyrazo les useful as sigma receptor inhibitors